Live
- Shafali Verma Dropped as India Names 16-Member Squad for December ODIs Against Australia
- Leaked! iPhone 17 Battery, Camera, Chipset, Design and Display Upgrades
- Kerala mulls increasing retirement age of govt employees to 57
- Credit, deposit growth now in line with each other in India: Report
- Very 'productive' meeting with PM Modi, says British PM Starmer
- Actor Satyadev in Bengaluru to promote Zebra movie
- Vijaya Chaitanya Palanki Leads the Development of Advanced Data Analytics Algorithms for Upsell Scoring, Churn Prediction, and Promotion Management
- Wanaparthy collector says Prajapalana Vijayotsava kaka yatra from 19 Nov to 7 Dec
- Hamas says security operation kills 20 aid truck looters
- Flipkart Mobiles Bonanza Sale: Top 5 Smartphone Deals with Great Discounts
Suven Life secures neuro drug patent from Australia
Highlights
Suven Life Sciences has received an approval from Australia for a patent on a drug used in the treatment of disorders associated with neurodegenerative diseases.
Hyderabad: Suven Life Sciences has received an approval from Australia for a patent on a drug used in the treatment of disorders associated with neurodegenerative diseases.
The company has been granted one product patent from Australia corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases, according to a communique to BSE.
“The patent is valid through 2034. Drugs for cognitive disorders with high unmet medical need with huge market potential globally,” Suven Life CEO Venkat Jasti said.
Next Story
ADVERTISEMENT
